FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/071952 [Registered on: 06/08/2024] Trial Registered Prospectively
Last Modified On: 02/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   A Study on the relation between platelets and liver enzymes with Liver fibroscan to find the severity of liver disease in patients who have non alcoholic fatty liver disease  
Scientific Title of Study   Association of APRI,FIB-4,AST/ALT with Fibroscan in Patients of Non Alcoholic Fatty Liver Disease for assesing Hepatic Fibrosis  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR.Nannaka Vikas 
Designation  Junior Resident 
Affiliation  Kasturba Medical College and Hospital manipal 
Address  Department of General Medicine, kasturba medical college , madhav nagar Manipal ,Udupi district,karnataka

Udupi
KARNATAKA
576104
India 
Phone  9640065306  
Fax    
Email  nannaka.kmcmpl2023@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Shubhada 
Designation  Associate professor  
Affiliation  Kasturba Medical College and Hospital Manipal 
Address  Department of General Medicine, Kasturba medical College ,Madhav Nagar Manipal,Udupi district, Karnataka state,India

Udupi
KARNATAKA
576104
India 
Phone  9844465447  
Fax    
Email  Shubhada.u@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr.Shubhada 
Designation  Associate Professor  
Affiliation  Kasturba Medical College and Hospital Manipal 
Address  Department of General Medicine Kasturba Medical College ,Madhav Nagar Manipal,Udupi district,Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9844465447  
Fax    
Email  Shubhada.u@manipal.edu  
 
Source of Monetary or Material Support  
Department of General Medicine Kasturba Medical College and Hospital madhav nagar Manipal,Udupi district,karnataka state ,India Pincode:576104 
 
Primary Sponsor  
Name  Department of general medicine 
Address  Kasturba Medical College and Hospital Madhav Nagar, Manipa,Udupi district,Karnataka state,India PIN code:576104 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Department of medical gastroenterology  Kasturba medical college madhav nagar Manipal  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrNannaka vikas  KASTURBA HOSPITAL MANIPAL  Department of General Medicine, Kasturba Medical College and Hospital, Madhav nagar,manipal,Udupi district, Karnataka state,India Pincode 576104
Udupi
KARNATAKA 
9640065396

nannaka.kmcmpl2023@learner.manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba medical college and Kasturba Hospital Institutional Ethics committee-Student Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K760||Fatty (change of) liver, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients who are diagnosed having NAFLD and NASH , undergoing fibrous scan in kasturba hospital Manipal 
 
ExclusionCriteria 
Details  Hepatitis B, hepatitis C, auto immune hepatitis, ITP ,history of herbal medication use, history of inherited jaundice 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Find out association of APRI,FIB-4,AST/ALT ration with fibroscan and using it for assessing hepatic fibrosis   Cross sectional study 
 
Secondary Outcome  
Outcome  TimePoints 
To find which score among these have better association with fibroscan   Cross sectional study 
 
Target Sample Size   Total Sample Size="113"
Sample Size from India="113" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study will recruit the patients of NAFLD who have underwent fibroscan and cbc,Lft in the a duration of one month both from op and IP of general medicine and medical gastroenterology
And APRI,FIB-4,AST/ALT ratio will be calculated and is used to find association with fibroscan in assessing hepatic fibrosis 
 
Close